Essential thrombocythemia: A review of diagnostic and pathologic features Review uri icon

Overview

MeSH Major

  • Thrombocythemia, Essential

abstract

  • ET is a relatively indolent and often asymptomatic CMPD that is characterized primarily by a sustained elevation in platelets > or = 600 x 10(3)/microL (> or = 600 x 10(9)/L), proliferating enlarged and hyperlobated megakaryocytes, and minimal to absent bone marrow fibrosis. Significant changes and revisions to the diagnostic requirements and criteria for ET have occurred during the last 30 years. Recently, a mutation in the Janus kinase 2 (JAK2) gene has been found in a significant number of cases of ET and other CMPDs. In up to 57% of ET cases, a mutation in the JAK2 gene can be detected. In the absence of a JAK2 mutation and features of another CMPD, the diagnosis of ET remains a diagnosis of exclusion after other causes of thrombocytosis have been excluded.

publication date

  • August 2006

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 16879015

Additional Document Info

start page

  • 1144

end page

  • 50

volume

  • 130

number

  • 8